Literature DB >> 15620606

Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery based study from 1969 to 1998.

Nebojsa Markovic1, Ivan Ignjatovic, Rade Cukuranovic, Branislav Petrovic, Biljana Kocic, Vladisav Stefanovic.   

Abstract

The incidence of upper urothelial tumors (UUT) and bladder tumors associated to Balkan endemic nephropathy (BEN) in the region of South Morava River in Serbia, in the 30-year period, was studied. A total of 575 urothelial neoplasms during 10-year period (1989-1998) was analyzed and compared to 659 urothelial neoplasms in the period from 1969 to 1988. UUT had 11.2-fold increased incidence in endemic than in nonendemic areas, however, this was far less than in the period from 1969 to 1988, when they were 57.1 times more frequent. Bladder tumors were 2.3 times more frequent in endemic than in nonendemic areas, but 11.9 times in the previous study from 1969 to 1988. Neoplasms from the area of BEN, regardless of their location, were not histologically different from the neoplasms out of endemic areas. Similarly to the previous reports that BEN looks like a disease that disappears, this is demonstrated also for urothelial tumors, which are the most frequent associated diseases.

Entities:  

Mesh:

Year:  2005        PMID: 15620606     DOI: 10.1016/j.patbio.2004.01.008

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  9 in total

1.  Upper urothelium carcinomas in Croatian endemic area.

Authors:  Ante Cvitković; Igor Ivić-Hofman; Dragana Jurić
Journal:  Wien Klin Wochenschr       Date:  2013-08-09       Impact factor: 1.704

2.  The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma.

Authors:  Dragica Milenkovic-Petronic; Bogomir Milojevic; Milan Djokic; Sandra Sipetic-Grujicic; Isidora Grozdic Milojevic; Uros Bumbasirevic; Zoran Dzamic
Journal:  Int Urol Nephrol       Date:  2013-09-21       Impact factor: 2.370

3.  Could disappearance of endemic (Balkan) nephropathy be expected in forthcoming decades?

Authors:  Ante Cvitković; Ivana Vuković-Lela; Karen L Edwards; Sandra Karanović; Dragana Jurić; Dubravka Cvorišćec; Mirjana Fuček; Bojan Jelaković
Journal:  Kidney Blood Press Res       Date:  2011-11-23       Impact factor: 2.687

4.  Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival.

Authors:  Bogomir Milojevic; Milan Djokic; Sandra Sipetic-Grujicic; Dragica Milenkovic-Petronic; Aleksandar Vuksanovic; Dejan Dragicevic; Uros Bumbasirevic; Cane Tulic
Journal:  Int Urol Nephrol       Date:  2011-02-26       Impact factor: 2.370

Review 5.  Historical review of the causes of cancer.

Authors:  Clarke Brian Blackadar
Journal:  World J Clin Oncol       Date:  2016-02-10

Review 6.  Balkan endemic nephropathy-current status and future perspectives.

Authors:  Nikola M Pavlović
Journal:  Clin Kidney J       Date:  2013-06

Review 7.  Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?

Authors:  Pierre Colin; Thomas Seisen; Romain Mathieu; Sharohkh F Shariat; Morgan Rouprêt
Journal:  Transl Androl Urol       Date:  2016-10

8.  Geographic distribution and risk of upper urothelial carcinomas in Croatia, 2001-2011.

Authors:  Danira Medunjanin; Zdenko Sonicki; John E Vena; Ante Cvitkovic; Sara Wagner Robb
Journal:  BMC Cancer       Date:  2019-10-15       Impact factor: 4.430

Review 9.  Balkan nephropathy: evolution of our knowledge.

Authors:  Giorgos Bamias; John Boletis
Journal:  Am J Kidney Dis       Date:  2008-09       Impact factor: 8.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.